2007
DOI: 10.1002/jhet.5570440524
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 2‐formyl‐1‐aza‐dibenzo[e,h]azulenes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…In the case of 4-[5-(4-fluorophenyl)-4-pyridine-4-yl-1H-pyrrol-2-yl]-1-methyl-piperidine-4-ol 41 [49], biological activity was confirmed with an IC50 value of 0.13 µM. However, 1H-8-oxa-1-aza-dibenzo[e,h]azulen1H-dibenzo[2,3:6,7]azepino [4,5-b]pyrrol [51,53] was not detected (IC50 > 10 µmol dm −3 ), indicating a lack of inhibitory activity. Table S1 in the Supplementary materials presents data collected by the authors of the article [49] on the inhibitory activity of 4-[5-(4-fluorophenyl)-4-pyridine-4-yl-1H-pyrrol-2-yl]-1-methyl-piperidine-4-ol derivatives, including DMHG, along with other heterocycles of similar structures.…”
Section: Dmhg In the Directed Synthesis Of Biologically Active Analog...mentioning
confidence: 98%
See 1 more Smart Citation
“…In the case of 4-[5-(4-fluorophenyl)-4-pyridine-4-yl-1H-pyrrol-2-yl]-1-methyl-piperidine-4-ol 41 [49], biological activity was confirmed with an IC50 value of 0.13 µM. However, 1H-8-oxa-1-aza-dibenzo[e,h]azulen1H-dibenzo[2,3:6,7]azepino [4,5-b]pyrrol [51,53] was not detected (IC50 > 10 µmol dm −3 ), indicating a lack of inhibitory activity. Table S1 in the Supplementary materials presents data collected by the authors of the article [49] on the inhibitory activity of 4-[5-(4-fluorophenyl)-4-pyridine-4-yl-1H-pyrrol-2-yl]-1-methyl-piperidine-4-ol derivatives, including DMHG, along with other heterocycles of similar structures.…”
Section: Dmhg In the Directed Synthesis Of Biologically Active Analog...mentioning
confidence: 98%
“…Attempts have been made to synthesize inhibitors of p38 MAP kinases (mitogenactivated protein kinases) based on DMHG [49][50][51], aiming to reduce the production of pro-inflammatory cytokines, which contribute to tissue destruction in diseases such as rheumatoid arthritis, an inflammatory joint disease. In one method [49] (Figure 6), the authors propose a DMHG-based condensation in an alkaline medium, alcohol solution, without the use of organometallic reagents.…”
Section: Dmhg In the Directed Synthesis Of Biologically Active Analog...mentioning
confidence: 99%